Kerala Ayurveda Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 288880,
    "name": "Kerala Ayurveda",
    "stock_name": "Kerala Ayurveda",
    "full_name": "Kerala Ayurveda Ltd",
    "name_url": "stocks-analysis/kerala-ayurveda",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "242.55",
    "chg": 14.45,
    "chgp": "6.33%",
    "dir": 1,
    "prev_price": "228.10",
    "mcapval": "297.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530163,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE817B01025",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "45.66 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kerala-ayurveda-288880-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kerala Ayurveda Sees Revision in Market Evaluation Amid Financial and Technical Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kerala-ayurveda-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3741235",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KeralaAyurveda_mojoScore_3741235.png",
        "date": "2025-12-02 10:09:20",
        "description": "Kerala Ayurveda, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting shifts in its financial health and technical outlook. This adjustment highlights ongoing challenges in the company’s fundamentals and market positioning, prompting investors to reassess its prospects amid sector dynamics."
      },
      {
        "title": "Why is Kerala Ayurveda falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kerala-ayurveda-fallingrising-3734187",
        "imagepath": "",
        "date": "2025-11-28 00:15:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Volatility and Trading Range</strong></p>\n<p>The stock demonstrated considerable price swings throughout the trading session, with an intraday high of ₹390, representing an 11.16% gain, and a low of ₹337, down 3.95% from the previous close. This wide range of ₹53 underscores the heightened volatility investors experienced during the day. The intraday volatility, calculated at 7.29% based on the weighted average price, further emphasises the stock’s fluctuating momentum.</p>\n<p>Despite this volatility, Kerala Ayurveda outperformed its sector peers by 9.94%, signalling strong relative strength in the current market context. The stock has also been on a positive trajectory over the last two days, delivering a cumulative return of 12.99%, which suggests renewed investor interest or shor..."
      },
      {
        "title": "Kerala Ayurveda Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kerala-ayurveda-forms-death-cross-signalling-potential-bearish-trend-3718714",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KeralaAyurveda_dealthcross_3718714.png",
        "date": "2025-11-20 18:00:25",
        "description": "Kerala Ayurveda, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price trajectory."
      },
      {
        "title": "Kerala Ayurveda Q2 FY26: Losses Deepen as Operating Margins Collapse",
        "link": "https://www.marketsmojo.com/news/result-analysis/kerala-ayurveda-q2-fy26-losses-deepen-as-operating-margins-collapse-3718758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KeralaAyurveda_quaterlyResult_3718758.png",
        "date": "2025-11-18 16:38:01",
        "description": "Kerala Ayurveda Ltd., a micro-cap pharmaceutical company specialising in Ayurvedic products and wellness services, reported a consolidated net loss of ₹6.34 crores for Q2 FY26, a sharp deterioration from a profit of ₹1.99 crores in Q1 FY26. The quarter-on-quarter decline of 418.59% and year-on-year plunge of 285.38% underscore mounting operational pressures that have eroded profitability despite modest revenue growth. The company's market capitalisation stands at ₹470.00 crores, with shares trading at ₹385.00 as of November 18, 2025."
      },
      {
        "title": "How has been the historical performance of Kerala Ayurveda?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kerala-ayurveda-3708574",
        "imagepath": "",
        "date": "2025-11-17 22:55:40",
        "description": "Answer:\nThe historical performance of Kerala Ayurveda shows significant fluctuations over the years, particularly in revenue and profitability.\n\nBreakdown:\nKerala Ayurveda's net sales have shown a steady increase from INR 58.90 crore in March 2019 to INR 120.33 crore in March 2025. However, the total expenditure has also risen sharply, leading to an operating profit (PBDIT) that turned negative at INR -4.99 crore in March 2025, down from INR 8.83 crore in March 2024. This decline in profitability is reflected in the profit before tax, which fell to INR -12.24 crore in March 2025, compared to a profit of INR 0.66 crore in the previous year. Consequently, the profit after tax also dropped significantly to INR -13.96 crore in March 2025, indicating a challenging financial environment. The company's total assets decreased slightly to INR 123.99 crore in March 2025 from INR 128.47 crore in March 2024, while tota..."
      },
      {
        "title": "How has been the historical performance of Kerala Ayurveda?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kerala-ayurveda-3702947",
        "imagepath": "",
        "date": "2025-11-14 23:39:32",
        "description": "Answer:\nThe historical performance of Kerala Ayurveda shows a fluctuating trend in its financial metrics over the years, culminating in a challenging fiscal year ending March 2025.\n\nBreakdown:\nKerala Ayurveda's net sales have shown a consistent upward trajectory, increasing from 58.90 crore in March 2019 to 120.33 crore in March 2025. However, the total expenditure has also risen significantly, reaching 125.32 crore in March 2025, leading to an operating profit (PBDIT) of -4.99 crore, a stark decline from the positive 8.53 crore reported in March 2024. This negative operating profit reflects a broader trend, as the company has faced losses in profit before tax, which stood at -12.24 crore in March 2025, compared to a marginal profit of 0.66 crore in the previous year. Consequently, the profit after tax has also turned negative, recording -13.96 crore in March 2025. The company's total liabilities decreased ..."
      },
      {
        "title": "When is the next results date for Kerala Ayurveda?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-kerala-ayurveda-3691069",
        "imagepath": "",
        "date": "2025-11-11 23:17:48",
        "description": "The next results date for Kerala Ayurveda is scheduled for 14 November 2025...."
      },
      {
        "title": "Why is Kerala Ayurveda falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kerala-ayurveda-fallingrising-3690732",
        "imagepath": "",
        "date": "2025-11-11 21:42:57",
        "description": "As of 11-Nov, Kerala Ayurveda Ltd's stock price is currently at Rs 380.00, reflecting a decrease of Rs 9.95 or 2.55%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 6.62% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also underperformed its sector by 2.42% today. Despite a rise in delivery volume by 31.27% against the 5-day average, the overall performance remains weak, with significant declines over the past week and month, showing losses of 5.28% and 15.17%, respectively.\n\nIn the broader market context, while Kerala Ayurveda's stock has experienced a notable decline, the benchmark Sensex has shown a slight increase of 0.49% over the past week and a gain of 1.66% over the past month. Year-to-date, the stock has underperf..."
      }
    ],
    "total": 208,
    "sid": "288880",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/kerala-ayurveda-288880"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "30-Jan-2026",
      "details": "Announcement under regulation 30 (LODR) Resignation of Company Secretary",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "20-Jan-2026",
      "details": "Postal Ballot Voting results",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "20-Jan-2026",
      "details": "Please find attached the voting results and scrutinizers report for the Postal ballot notice issued on December 19 2025. This is to further inform you that all the resolutions contained in the notice has been duly passed by the Members.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kerala Ayurveda Sees Revision in Market Evaluation Amid Financial and Technical Challenges

2025-12-02 10:09:20

Kerala Ayurveda, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting shifts in its financial health and technical outlook. This adjustment highlights ongoing challenges in the company’s fundamentals and market positioning, prompting investors to reassess its prospects amid sector dynamics.

Why is Kerala Ayurveda falling/rising?

2025-11-28 00:15:35

Intraday Volatility and Trading Range The stock demonstrated considerable price swings throughout the trading session, with an intraday high of ₹390, representing an 11.16% gain, and a low of ₹337, down 3.95% from the previous close. This wide range of ₹53 underscores the heightened volatility investors experienced during the day. The intraday volatility, calculated at 7.29% based on the weighted average price, further emphasises the stock’s fluctuating momentum. Despite this volatility, Kerala Ayurveda outperformed its sector peers by 9.94%, signalling strong relative strength in the current market context. The stock has also been on a positive trajectory over the last two days, delivering a cumulative return of 12.99%, which suggests renewed investor interest or shor...

Kerala Ayurveda Forms Death Cross Signalling Potential Bearish Trend

2025-11-20 18:00:25

Kerala Ayurveda, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price trajectory.

Kerala Ayurveda Q2 FY26: Losses Deepen as Operating Margins Collapse

2025-11-18 16:38:01

Kerala Ayurveda Ltd., a micro-cap pharmaceutical company specialising in Ayurvedic products and wellness services, reported a consolidated net loss of ₹6.34 crores for Q2 FY26, a sharp deterioration from a profit of ₹1.99 crores in Q1 FY26. The quarter-on-quarter decline of 418.59% and year-on-year plunge of 285.38% underscore mounting operational pressures that have eroded profitability despite modest revenue growth. The company's market capitalisation stands at ₹470.00 crores, with shares trading at ₹385.00 as of November 18, 2025.

How has been the historical performance of Kerala Ayurveda?

2025-11-17 22:55:40

Answer: The historical performance of Kerala Ayurveda shows significant fluctuations over the years, particularly in revenue and profitability. Breakdown: Kerala Ayurveda's net sales have shown a steady increase from INR 58.90 crore in March 2019 to INR 120.33 crore in March 2025. However, the total expenditure has also risen sharply, leading to an operating profit (PBDIT) that turned negative at INR -4.99 crore in March 2025, down from INR 8.83 crore in March 2024. This decline in profitability is reflected in the profit before tax, which fell to INR -12.24 crore in March 2025, compared to a profit of INR 0.66 crore in the previous year. Consequently, the profit after tax also dropped significantly to INR -13.96 crore in March 2025, indicating a challenging financial environment. The company's total assets decreased slightly to INR 123.99 crore in March 2025 from INR 128.47 crore in March 2024, while tota...

How has been the historical performance of Kerala Ayurveda?

2025-11-14 23:39:32

Answer: The historical performance of Kerala Ayurveda shows a fluctuating trend in its financial metrics over the years, culminating in a challenging fiscal year ending March 2025. Breakdown: Kerala Ayurveda's net sales have shown a consistent upward trajectory, increasing from 58.90 crore in March 2019 to 120.33 crore in March 2025. However, the total expenditure has also risen significantly, reaching 125.32 crore in March 2025, leading to an operating profit (PBDIT) of -4.99 crore, a stark decline from the positive 8.53 crore reported in March 2024. This negative operating profit reflects a broader trend, as the company has faced losses in profit before tax, which stood at -12.24 crore in March 2025, compared to a marginal profit of 0.66 crore in the previous year. Consequently, the profit after tax has also turned negative, recording -13.96 crore in March 2025. The company's total liabilities decreased ...

When is the next results date for Kerala Ayurveda?

2025-11-11 23:17:48

The next results date for Kerala Ayurveda is scheduled for 14 November 2025....

Why is Kerala Ayurveda falling/rising?

2025-11-11 21:42:57

As of 11-Nov, Kerala Ayurveda Ltd's stock price is currently at Rs 380.00, reflecting a decrease of Rs 9.95 or 2.55%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 6.62% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also underperformed its sector by 2.42% today. Despite a rise in delivery volume by 31.27% against the 5-day average, the overall performance remains weak, with significant declines over the past week and month, showing losses of 5.28% and 15.17%, respectively. In the broader market context, while Kerala Ayurveda's stock has experienced a notable decline, the benchmark Sensex has shown a slight increase of 0.49% over the past week and a gain of 1.66% over the past month. Year-to-date, the stock has underperf...

View All News